Aethlon Medical, Inc. (AEMD) vs Revelation Biosciences, Inc. (REVB)
A side-by-side comparison of Aethlon Medical, Inc. and Revelation Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AEMD
Aethlon Medical, Inc.
$6.20HealthcareDelayed quote: Oct 6, 2026, 1:54 PM EDT
REVB
Revelation Biosciences, Inc.
$0.78HealthcareDelayed quote: Oct 6, 2026, 1:39 PM EDT
Total return — AEMD vs REVB
growth of $100 · dividends reinvested · last 6yAEMD -99.9% (-67.7%/yr)REVB -100.0% (-89.7%/yr)AEMD compounded faster over this window
Log scale — wide-divergence pair
AEMD REVB
AEMD vs REVB: by the numbers
- •AEMD is the larger company ($3M vs $3M market cap).
Metrics side by side
Valuation
| Metric | AEMD | REVB |
|---|---|---|
| P/B ratio | 0.63 | 0.30 |
Profitability
| Metric | AEMD | REVB |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -133.43% | -106.79% |
| ROIC | -133.29% | -104.28% |
Growth (annualized)
| Metric | AEMD | REVB |
|---|---|---|
| Total return CAGR (5Y) | -78.27% | -93.52% |
Frequently asked
- How have AEMD and REVB total returns compared?
- Over the past 5 years, AEMD delivered -78.27% and REVB delivered -93.52% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.